Sudden death prophylaxis in heart failure

Area of Science:

• Cardiology
• Electrophysiology
• Heart Failure Management

Background:

• Sudden cardiac death (SCD) is the primary cause of mortality in patients with heart failure (HF).
• Implantable cardioverter-defibrillators (ICDs) are widely used for SCD prevention in HF patients with low ejection fraction (EF), but EF alone is insufficient for risk stratification.
• Left ventricular mechanical dyssynchrony is an emerging risk marker for cardiac mortality in HF.

Purpose of the Study:

• To review the evidence for implantable ICDs and cardiac resynchronization therapy (CRT) in primary SCD prevention in HF.
• To discuss controversial clinical aspects of device therapy in HF.
• To recommend practical, evidence-based strategies for device management in HF patients.

Main Methods:

• Systematic review of published evidence on ICDs and CRT for SCD prophylaxis in HF.
• Analysis of clinical data and guidelines regarding risk stratification beyond ejection fraction.
• Discussion of controversial issues and formulation of management recommendations.

Main Results:

• Ejection fraction (EF) alone does not reliably differentiate between sudden arrhythmic death and non-sudden death in HF.
• Electrophysiologic studies and microvolt T-wave alternans testing may improve risk stratification for ICD implantation.
• Echocardiography for assessing left ventricular mechanical dyssynchrony is recommended over QRS duration measurement for CRT candidacy.

Conclusions:

• Optimizing patient selection for ICD and CRT is crucial to improve outcomes and minimize unnecessary device implants in HF.
• Integrating assessment of mechanical dyssynchrony with SCD risk factors allows for better application of CRT and ICD therapies.
• Further research and clinical consensus are needed to refine device-based management strategies for HF patients at risk of SCD.